DarioHealth (DRIO) investor relations material

Platform overview and market opportunity

• AI-powered, multi-condition platform addresses cardiometabolic, behavioral, and musculoskeletal health, supporting up to 6+ conditions on a single digital platform.

• Unified offering delivers personalized care, cost savings, and efficiency, with bundled pricing at $74 per engaged member per month.

• Large serviceable addressable market estimated at over $250 billion, with rapid expansion enabled by platform architecture.

• 70% of new wins and pipeline opportunities are multi-condition, reflecting strong market demand.

• Blue-chip client base includes 160+ clients and partnerships with major employers, health plans, and pharma.

Clinical outcomes and user engagement

• Over 100 published peer-reviewed studies validate clinical outcomes, including significant reductions in blood pressure, A1C, pain, and mental health symptoms.

• 5x ROI delivered to payers, with $5,077 in medical cost savings per user and 23% fewer hospitalizations.

• 75% of member measurements are in range, and 91% logo retention year-over-year.

• Average member retention rate after 12 months is 75%, with 2.4 solutions used per member.

• App Store rating of 4.8/5 from ~25,000 reviews highlights strong user satisfaction.

Technology and product differentiation

• Proprietary AI leverages 13B+ user data points for personalized care, workflow optimization, and predictive analytics.

• DarioIQ platform delivers adaptive, immersive health journeys, real-time data visualization, and timely interventions.

• Multi-modal support includes connected devices, AI-powered coaching, community, and clinical services.

• GLP-1 utilization management program integrates digital and live coaching, therapy, and medication support.

• Asset-light model enables seamless access to therapy and specialty care via partner networks.